cs.CVOct 19, 2026

How Robust Are Prognostic Radiomic Features? Comparing Selection Techniques on Pooled Glioblastoma Cohorts

Authors: Yannick Sodonougbo, Marlene Schnieders, Alexia Rizoudis, Santiago Cepeda, Frank Kramer, Dominik Müller

Organizations: IT Infrastructure for Translational Medical Research, University of Augsburg · Department of Neurosurgery, Río Hortega University Hospital · Specialized Group in Biomedical Imaging and Computational Analysis, Instituto de Investigación Biosanitaria de Valladolid · Department of Computer Science, Ulm University of Applied Sciences

Abstract

Radiomic survival studies in glioblastoma report heterogeneous prognostic features, but how much of this stems from the methodology itself is rarely examined. We analysed the association of 463 radiomic, anatomical and clinical features from pre-treatment MRI with overall survival in 705 IDH-wildtype glioblastoma patients from three public cohorts, using three techniques: a log-rank test after median split, univariate Cox regression (both Benjamini-Hochberg corrected) and an XGBoost regressor interpreted with SHAP. The log-rank test selected 99 features, Cox regression 72 and SHAP its top 20; five were selected by all three: age, a peritumoural T2 texture feature, the number of connected peritumoural mask components and two image-level intensity maxima. The two survival tests shared 51 features, about half of the SHAP top 20 were also selected by either test, and where selections overlapped, effect directions agreed. Many selections were PyRadiomics diagnostic descriptors that are not restricted to tumour voxels. Analytical pipeline choices, including ranking method, pre-filtering and descriptor handling, can substantially influence which features appear prognostic.

Figures & tables

Explore similar work

CardsList
  1. Segmentation Robustness and Predictive Utility in Glioblastoma Radiomics: Evidence for a Trade-off in Survival Modelling

    Jul 26, 2026Mariya Miteva, Maria Nisheva-PavlovaCancer Survival PredictionRadiomics

  2. Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study

    May 11, 2026Prajwal Ghimire, Junjie Li, Liu Yaou +2Clinical PredictionOncology

  3. CFB-GBM v2.0: An Augmented Longitudinal Dataset for Multi-Modal Glioblastoma Segmentation, Radiomics, and RANO Progression Tracking

    Aug 18, 2026Alexandre G. Leclercq, Noémie N. Moreau, Hugo Audebert +21Medical Image BenchmarksBrain Tumor Segmentation